X

Drug Profile

I-125 monoclonal antibody A33

Alternative Names: A33-radionuclides; CDP 833; hA33 90Y

Latest Information Update: 25 Jan 1999

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Celltech Group
Class Antineoplastics; Monoclonal antibodies; Radiopharmaceuticals
Mechanism of Action Undefined mechanism

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued Colorectal cancer

Most Recent Events

25 Jan 1999 Discontinued-I for Colorectal cancer in USA (IV)
01 Oct 1997 A study has been added to the therapeutic trials and adverse events sections
20 Aug 1997 CDP 833 is now called I-125 monoclonal antibody A33

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com